Close Menu

NEW YORK – Genome engineering firm Synthego said on Wednesday that it has raised $100 million in a Series D financing round.

The round was led by new investor Wellington Management, as well as by RA Capital Management and 8VC. Founders Fund, Menlo Ventures, and Intel Capital also participated, the company said, noting that this new round brings its total private funding raised to more than $250 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.